The US Food and Drug policy has granted vague approval for Isentress (raltegravir) tablets to be used along with other antiretroviral agents for HIV-1 insanitation for adult career who have confirmation of viral replication and who have developed resistance to variegated antiretroviral agents. Further trials will be needed before inasmuch as its approval for new HIV vocation and children. [click link for full article]

More: - From the site